StockWatch
·

M.M.FORGINGS LTD.-$ Q1 FY27 Results

MMFLQ1 FY27 Results
Filing
Result:Good· Market: Flat#Margin expansion#Base effect#One-off gain

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY26
Revenue409.9013.3%
Total Income426.7615.5%
Expenditure391.6914.6%
PBT91.32229.8%
Net Profit90.42371.3%
OPM29.43%11.92pp
NPM21.19%16.00pp
EPS18.73371.8%
View full financials

Revenue grew a solid 13.3% YoY with strong core margin expansion (OPM 17.5%→29.4%, NPM 5.2%→21.2%), but the 371% PAT jump is amplified by a depressed year-ago base and an unusually low effective tax rate this quarter (~1% vs ~31% last year), so it's healthy rather than a true standout.

M.M. FORGINGS LTD. · Q1 FY-2027 · THE VERDICT

Record PAT, but 64% from a land sale — the organic story is far quieter

Headline profit surged 371% to ₹90.4 Cr, but a ₹58 Cr land sale drives two-thirds of the gain. Strip that out, and organic earnings growth is 20–30% — while revenue missed internal guidance by ₹17 Cr. The question: can the underlying business deliver on FY27 targets?

21 Aug 2026 · 6 min read
Reported PAT

₹90.4 Cr

+371% YoY (includes one-time)

Land sale (post-tax)

₹58 Cr

64% of reported growth

Organic PAT

~₹32 Cr

+20–30% YoY estimated

Revenue vs guidance

₹410 Cr

₹17 Cr below stated ₹427 Cr

On the headline — a record profit that catches breath. On the call — management deflecting on a shortfall that shouldn't have happened. The street rewarded the result anyway, sending the stock up 7.2% on day one and 11.5% by day three, anchored to what it saw underneath: robust operational leverage, a capacity ramp that's actually tracking, and tailwinds (U.S. Class 8, India CV cycle) that remain intact. But the gap between reported and organic earnings is too large to ignore. The real number to track from here is whether management can execute the FY27 volume targets without another one-time crutch.

Where the profit actually came from

Management took a ₹60 Cr gross profit (₹58 Cr net) from an unrealized land sale in Q1. That single transaction represents 64% of the ₹90.4 Cr reported PAT and 100% of the 371% year-over-year growth. Strip it out, and organic PAT sits at roughly ₹32 Cr — a respectable 20–30% organic expansion, but a world away from the headline.

Q1 FY27 PAT, ₹ Cr
033.7567.5101.2590.4Reported PAT58Land sale (net)32.4Organic PAT
The land sale inflates reported profit by 179%. Organic growth is solid but not exceptional.

This matters because the quarter's real story — operational performance — is cleaner than the headline suggests. OPM at 29.4% is strong and reflects the mix shift (67% machining, up from 61% two years ago) and pricing power (₹1.93 Lakh/ton to ₹2.02 Lakh/ton). EBITDA roughly ₹120 Cr at 18% margin, flat year-over-year but stable despite fuel cost spikes (West Asian conflict drove power/freight inflation in Q1). The operational leverage is real; it just doesn't need a land sale to shine.

The revenue miss: claims vs. reality

Management's on-call claims and what the numbers actually show

Revenue ₹427 Cr, growth 16%

₹409.9 Cr, growth 13.3%

Overstated by ₹17 Cr; a 4.2% miss

U.S. market strong, Class 8 tailwind intact

U.S. now 18% of sales (up 2pp). Sales/ton improved.

Supported

Machining mix 67%, target 65–68% full year

Delivered 67% in Q1; ₹625 Cr capex in last 5 years confirms priority

Supported

All lines running at fullest capability; 15–20% debottleneck room

Capacity utilization high but conflicting claims on slack

Partially supported; some ambiguity

The revenue shortfall is not trivial. At ₹410 Cr in Q1, the company needs to hit ₹475–500 Cr in each of Q2–Q4 to reach the ₹1,800–1,900 Cr FY27 guidance — a 18–22% quarter-on-quarter jump from Q1's base. That requires the volume ramp (from 20k tons in Q1 to 23–25k tons/qtr target) to land flawlessly. Management says June already showed 24k+ run-rate, a bullish signal. But the Q1 miss is fresh evidence that execution, not demand, is the constraint.

What changed on this call

Shifts vs. prior call (Q4 FY-2026)
  • FY27 guidance maintained at ₹1,800–1,900 Cr (18% growth), but Q1 shortfall raises execution risk

  • EBITDA margin target steady at 20%+ (from 18%); MD has 1–2pp visibility, 2–3pp is challenge

  • U.S. tailwind explicitly quantified: now 18% of sales, guiding 1–2pp more growth this year

  • Europe revenue softness worsened: down from ₹82 Cr (Q2 FY26) to ₹59 Cr (Q1 FY27) — a 28% four-quarter decline

  • Prior guidance on interest cost (₹55 Cr target) and power savings (₹15 Cr) not reaffirmed this call

  • Working capital intensity worsened: 30% of revenue growth vs. 23% norm; AI-driven fix in early stages

  • Hyperscaler business (Abhinava Rizel customer) in SOP phase ramp; early-stage execution risk

The bull-bear ledger

  • U.S. Class 8 truck market recovery is structural and durable; 18% of sales now, growing

  • India CV cycle strong and broad-based; 71% of sales, multiple customer wins across segments

  • Machining ramp (67% of mix) unlocking higher margins and customer stickiness; ₹625 Cr invested in capex over 5 years

  • Pricing power evident: ₹1.93 Lakh/ton to ₹2.02 Lakh/ton in one quarter

  • New capacity (16.5k-ton and 4k-ton presses) in production; automation investment ₹7.5–10 Cr last 3 qtrs, tripling to ₹30–50 Cr by FY27-end

  • Q1 revenue miss (₹410 vs ₹427 claimed; 4.2% shortfall) signals execution gaps, not demand weakness

  • Reported PAT inflated 179% by land sale; organic growth 20–30%, masking operational momentum

  • Working capital deteriorated to 30% of revenue growth from 23% norm; stuck inventory a drag

  • Europe revenue in four-quarter downtrend (₹82→59 Cr); unclear if customer loss or cyclical demand fluctuation

  • EBITDA margin expansion (18%→20%) requires flawless execution on cost, volume, and pricing simultaneously

  • Capacity expansion roadmap (27–30k tons/qtr) aggressive; labor shortage acknowledged in Apr–May, though recovered by June

How the market read it

The street focused on operational substance, not balance-sheet cosmetics. The day-1 pop of 7.21% and day-3 cumulative gain of 11.54% held reasonably close to those levels (current price ₹652.6, 5.1% off its all-time high of ₹687.9). The stock trades well above its 20-day, 50-day, and 200-day moving averages (₹603, ₹538, ₹444 respectively), and RSI sits neutral at 65.3. Volume is increasing, signaling growing retail and institutional interest.

Ownership reveals institutional caution: FII ownership ticked up 58bp to 2.44% in Q1, but from a low base. DII ownership fell 88bp to 7.49%, suggesting some profit-taking or rotation. Promoter holding remains locked at 56.34%, which is the real support — long-term alignment. The modest FII pickup on a headline-beat result (despite organic softness) reflects the market's belief in the macro tailwinds outweighing near-term execution risks.

Ranked risks: what should concern a holder

Risks ordered by severity for a shareholder

FY27 revenue guidance execution (₹1,800–1,900 Cr requires 23–25k tons/qtr from Q2+)

High

Q1 shortfall (₹410 vs ₹427) plus tight guidance leaves zero room for error. Volume ramp must hit perfectly; any slip delays target.

Working capital intensity (30% vs 23% norm) deteriorated; stuck inventory a cash drain

High

WC swallows 30% of revenue growth gains, starving capex and debt paydown. AI-driven fix only 2–3 months into deployment; full benefit uncertain.

EBITDA margin expansion (18%→20%) leaves no room for macro headwinds

Medium

MD has visibility on 1–2pp, but 2–3pp is 'challenge for the team.' Any inflation, capacity underutilization, or pricing pressure kills the target.

Europe revenue soft and sliding (₹82→59 Cr over 4 qtrs, down 28%)

Medium

MD dismisses as 'customer demand fluctuation' but no clarity on whether it's cyclical or structural. If European OEMs consolidating to low-cost competitors, MM loses a meaningful market.

Hyperscaler business (Abhinava Rizel) in early ramp; commercial scale unproven

Medium

New customer segment but unproven contract terms, volumes, and margins. Single-customer concentration risk if it becomes 10%+ of revenue.

Capacity quantification opaque; MD deflected on CNC machine count

Low

Without clear mapping of equipment→capacity→revenue, hard to audit the ₹2,100 Cr gross block and ₹3,000 Cr FY30 revenue target claims.

The debate

What to watch next

Three concrete signals that resolve the debate
  • 1 · Q2 volume execution (due Oct–Nov 2026)

    If Q2 hits 23–25k tons with revenue ₹450+ Cr, FY27 guidance is live. If volume stalls at 21k tons or revenue slides to ₹420 Cr, the ramp is at risk and targets slip to FY28.

  • 2 · Working capital normalization

    AI-driven fix should show results by Q3. If WC stays at 30% of revenue growth, cash conversion remains weak and capex funding gets squeezed. If it normalizes to 23%, confidence in FY27 margins rises sharply.

  • 3 · Europe trajectory stabilization

    Q2–Q3 should show whether Europe is bottoming (customer loss priced in) or continuing to decay. A stabilization at ₹55–60 Cr/qtr is acceptable; further decline to ₹50 Cr suggests structural loss.

The single number to track

Strip out the land sale and the real story emerges: organic PAT growth of 20–30% is good, not exceptional, against a macro backdrop this favorable. The revenue miss (₹17 Cr shortfall on ₹427 Cr claimed) is the early warning. Management has the structural tailwinds (U.S. Class 8, India CV, machining ramp) to deliver the FY27 target, but execution on volume (23–25k tons/qtr from Q2 onwards) is now the gate. Working capital intensity at 30% of revenue growth, versus the 23% norm, is a 700bp drag that must reverse or FY27 margins stall. The market is right to own the long-term (structural demand intact), but wrong to overlook the near-term (execution gap is real). Hold the position if you own it; trim on rallies above ₹670; add on dips below ₹600 only after Q2 proves volume targets are real. The number to watch from here is organic PAT, not reported PAT — ₹32 Cr this quarter, and it should grow to ₹40+ Cr in Q2 if the ramp is tracking.

Informational and educational content only. Not investment advice.